"Innovation in medicine is driven by need, but also by the market,"
said Dr. Michael R. Harrison, the director emeritus of the Fetal
Treatment Center and the director of the Pediatric Device
Consortium, both at the University of California, San Francisco.
"Big markets have lots of folks developing devices, but small
markets like the pediatrics market don't."
Maternal Liver Grafts More Tolerable for Children with Rare Disease
UCSF Department of Surgery - November 16, 2012
Children with a rare, life-threatening disease that is the
most common cause of neonatal liver failure - biliary atresia -
better tolerate liver transplants from their mothers than from
their fathers, according to a UCSF-led
study......"This result is exciting because it supports the
concept that trafficking of cells between the mother and the fetus
has functional significance long after the pregnancy is over," said
senior author Tippi MacKenzie, M.D.,
assistant professor of pediatric surgery at UCSF and a fetal
surgeon at UCSF Benioff Children's Hospital. "This is a
topic we are actively studying both in animal models and in
patients who have fetal surgery. Practically speaking, this study
may allow us to counsel families in which both the mother and
father are willing and able to be a donor."
Ronald McDonald House Charities Honor UCSF’s Michael Harrison
UCSF News - November 02, 2012
Michael R. Harrison, MD, founder and director emeritus of the
Fetal Treatment Center at the UCSF Benioff Children's Hospital, was
recognized last week for his contributions to life-saving fetal
surgery with the Ronald McDonald House Charities Medical Award of
Excellence.
"Inside Surgery", The Department of Surgery Newsletter, Summer 2012
UCSF Department of Surgery - August 22, 2012
This issue of Inside Surgery describes several exciting
developments that are advancing our ability to provide outstanding
care for a range of patients including the new Hepatobiliary
Service, under the direction of Carlos
Corvera, M.D., which provides comprehensive,
multidisciplinary care for patients with liver and bile duct
disease. Other topics include updates on Endocrine
Surgery, San Fancisco General Hospital's Wraparound Project, and
notable rankings of our surgeons within U.S. News & World
Report annual update.
Magnet trial an attractive option for kids with sunken chest
Reuters - August 19, 2012
Surgeons at the UCSF Benioff Children's Hospital in San
Francisco are using magnets to reshape the breastbones of children
who suffer from Sunken Chest Syndrome. The technique is undergoing
phase 3 clinical trials, but the doctors hope to prove that long
term magnetic force is as effective and less painful than
conventional surgery.
The Society of Clinical Trials has named
UCSF's Management of Myelomeningocele Study (MOMS), a review of
prenatal versus postnatal surgery for myelomengingocele (spina
bifida), as its Trial of the Year. The study earned
recognition as an important clinical trial that overcame
difficulties and produced remarkable results.
Magnets May Pull Kids With Sunken Chests Out Of Operating Room
NPR - July 30, 2012
A new method for repairing Pectus Exacavatum using magnets
and an external brace, developed by Michael
Harrison, a pediatric surgeon at the University of
California, San Francisco's Benioff
Children's Hospital, could provide an alternative to the
surgery.
Kids With Chest Wall Deformities Get Comprehensive Care at Clinic
UCSF News - July 09, 2012
Justin is being treated at the UCSF Comprehensive Center
for Chest Wall Deformities, a new interdisciplinary pediatric
clinic at UCSF Benioff Children's
Hospital that offers a wide range of interventions
for children with all types of chest wall deformities, from common
to complex. Justin has the most common chest wall deformity called
pectus excavatum, a congenital disorder which causes the chest to
have a sunken or "caved in" appearance.
Amar Nijagal, M.D. awarded M. Judah Folkman Memorial Award for two consecutive years
UCSF - June 21, 2012
Dr. Amar Nijagal was awarded the M. Judah Folkman Memorial Award
by the American Pediatric Surgical Association at the 2012 APSA
Annual meeting for his work entitled "Fetal Intervention Triggers
the Activation of Paternal Antigen-Specific Maternal T Cells." Dr.
Nijagal is currently a General Surgery resident at UCSF and has
worked in Dr. Tippi MacKenzie's laboratory in the UCSF Division of
Pediatric Surgery for the past three years. In 2011, he was also
awarded the M. Judah Folkman Memorial Award for his presentation on
"The Maternal Adaptive Immune Response Against Paternal Antigens
Incites Fetal Demise After Fetal Intervention". This award is
bestowed annually for the most outstanding research presentation
given during the APSA Annual Meeting. Dr. Eric Jelin also received
this award in 2009 for his work on the "Effects of Notch4 On Lung
Vascular Remodeling."
UCSF Pediatric Surgery publishes CDH patient guidebook for iPad
UCSF - May 25, 2012
UCSF Pediatric Surgery has published thier first interactive
Patient Guide iBook for the iPad. This multimedia guidebook is a
free educational resource for families who are faced with
Congenital Diaphragmatic Hernia (CDH). More guidebooks are being
planned as well as epub versions for other ebook readers.
The inspiration for this project is a direct result of the
generous support of the CDH research and patient education
grant provided by the Nayeli Faith Foundation.
Hanmin Lee, M.D. appointed Surgeon in Chief of UCSF Benioff Children's Hospital
UCSF - May 10, 2012
Dr. Hanmin
Lee has been named Surgeon in Chief of the UCSF Benioff
Children's Hospital. Dr. Lee has been a champion for pediatric
surgical care in the Department of Surgery for many years. He
is a professor of Clinical Surgery, Pediatrics, and Obstetrics,
Gynecology & Reproductive Sciences and his leadership
roles include Chief of the Division of Pediatric Surgery
and Director of the UCSF Fetal Treatment
Center. In his new role as Surgeon in Chief, he will be
responsible for inpatient and ambulatory surgical care and the
continuum of preoperative, intraoperative, and postoperative care
of surgical patients. He will lead the effort in building and
fostering relationships with referring physicians and organizations
in San Francisco and throughout the Bay Area, and will take a
leadership role in the planning for operations in the new UCSF
Benioff Children's Hospital at Mission Bay.
Hanmin Lee, M.D. Selected as one of UCSF’s "Exceptional Physicians of 2012"
UCSF - April 17, 2012
Hanmin
Lee, M.D. has been selected as one of the UCSF Medical
Center's "Exceptional Physicians of 2012". Dr.
Lee is Professor, Surgery, Pediatrics, Ob-Gyn and Reproductive
Health Services, Chief of the Division of Pediatric
Surgery, Director of the UCSF Fetal Treatment Center, and
the Surgeon-in-Chief of UCSF Benioff Children's Hospital. This
award is given annually to physicians who have distinguished
themselves as role models and demonstrate the values
of UCSF Medical Center, namely professionalism, respect,
integrity, diversity and excellence.
Surgeons Seek Kid-Sized Tools for the Operating Room
KQED Quest - January 27, 2012
UCSF has received about a million dollars since 2009. That money
has supported the development of tools to treat scoliosis, kidney
failure and sunken chest, among other conditions. The pectus, or
sunken chest device, is in clinical trials.
UCSF Consortium Collaborates to Invent Medical Devices for Children
UCSF News - November 01, 2011
The UCSF "D'Vice Squad," a group of innovators from across the
Bay Area, has drawn from diverse disciplines over the last two
years to develop medical devices for children.
Now the squad's hard work has been rewarded with a $1 million
grant from the U.S. Food and Drug Administration (FDA) to expand
its work over the next two years.
Doctors call Vilma Zarate's role as an administrative analyst in
University of California, San Francisco's fetal surgery department
invaluable to both faculty and patients. For faculty, Zarate
carefully crafts grant and funding applications and coordinates
clinical trials. Patients, on the other hand, benefit from the
clear and thoughtful consent documents Zarate creates to help them
understand the risks of cutting-edge medicine.